P076 Safety of higher doses of melatonin in adults: A systematic review and meta-analysis. (9th November 2022)
- Record Type:
- Journal Article
- Title:
- P076 Safety of higher doses of melatonin in adults: A systematic review and meta-analysis. (9th November 2022)
- Main Title:
- P076 Safety of higher doses of melatonin in adults: A systematic review and meta-analysis
- Authors:
- Menczel Schrire, Z
Phillips, C
Gordon, C
Naismith, S
Marshall, N
Grunstein, R - Abstract:
- Abstract: Introduction: Melatonin is commonly used for sleep and jetlag at low doses. There is less documentation on the safety of higher doses which are being increasingly used for a wide variety of conditions. This systematic review aimed to investigate the safety of higher doses of melatonin in adults. Methods: We searched Medline, Scopus, Embase and PsycINFO databases from study inception until December 2019 with convenience searches until October 2020. The inclusion criteria were randomised controlled trials investigating high-dose melatonin (≥10mg) in human adults over 30 years of age. The outcomes examined were the number of adverse events (AEs), serious adverse events (SAEs) and withdrawals due to AEs. A meta-analysis was conducted on studies lasting 3 months or longer. Results: 79 studies were identified with a total of 3861 participants. 29 studies (37%) made no mention of the presence or absence of AEs. Only 4 studies met the pre-specified low-risk of bias criteria for meta-analysis. In that small subset, melatonin did not cause a detectable increase in SAEs (Rate Ratio=0.88 [0.52, 1.50], p=0.64) or withdrawals due to AEs (0.93 [0.24, 3.56], p=0.92), but did appear to increase the risk of AEs such as drowsiness, headache, and dizziness (1.40, [1.15, 1.69], p<0.001). Discussion: There has been limited AE reporting from high-dose melatonin studies. Based on this limited evidence, melatonin appears to have a good safety profile. Better safety reporting in futureAbstract: Introduction: Melatonin is commonly used for sleep and jetlag at low doses. There is less documentation on the safety of higher doses which are being increasingly used for a wide variety of conditions. This systematic review aimed to investigate the safety of higher doses of melatonin in adults. Methods: We searched Medline, Scopus, Embase and PsycINFO databases from study inception until December 2019 with convenience searches until October 2020. The inclusion criteria were randomised controlled trials investigating high-dose melatonin (≥10mg) in human adults over 30 years of age. The outcomes examined were the number of adverse events (AEs), serious adverse events (SAEs) and withdrawals due to AEs. A meta-analysis was conducted on studies lasting 3 months or longer. Results: 79 studies were identified with a total of 3861 participants. 29 studies (37%) made no mention of the presence or absence of AEs. Only 4 studies met the pre-specified low-risk of bias criteria for meta-analysis. In that small subset, melatonin did not cause a detectable increase in SAEs (Rate Ratio=0.88 [0.52, 1.50], p=0.64) or withdrawals due to AEs (0.93 [0.24, 3.56], p=0.92), but did appear to increase the risk of AEs such as drowsiness, headache, and dizziness (1.40, [1.15, 1.69], p<0.001). Discussion: There has been limited AE reporting from high-dose melatonin studies. Based on this limited evidence, melatonin appears to have a good safety profile. Better safety reporting in future long-term trials is needed to confirm this as our confidence limits were very wide due to the paucity of suitable data. … (more)
- Is Part Of:
- Sleep advances. Volume 3(2022)Supplement 1
- Journal:
- Sleep advances
- Issue:
- Volume 3(2022)Supplement 1
- Issue Display:
- Volume 3, Issue 1 (2022)
- Year:
- 2022
- Volume:
- 3
- Issue:
- 1
- Issue Sort Value:
- 2022-0003-0001-0000
- Page Start:
- A54
- Page End:
- A55
- Publication Date:
- 2022-11-09
- Subjects:
- Sleep disorders -- Periodicals
Circadian rhythms -- Periodicals
616.8498 - Journal URLs:
- http://www.oxfordjournals.org/ ↗
https://academic.oup.com/sleepadvances/issue ↗ - DOI:
- 10.1093/sleepadvances/zpac029.146 ↗
- Languages:
- English
- ISSNs:
- 2632-5012
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 24679.xml